What is Bellevue Life Sciences Acquisition Corp. (BLAC)?

Bellevue Life Sciences Acquisition Corp. (BLAC) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of BLAC?

The current price of BLAC is $3.01. Prices are updated in real time on Stocks360.

What is BLAC's price-to-earnings (PE) ratio?

BLAC's trailing twelve-month PE ratio is 0.84, based on current price and earnings per share data available on Stocks360.

What is BLAC's market capitalization?

BLAC's market capitalization is $6,982,448.00, placing it in the small-cap tier.

Bellevue Life Sciences Acquisition Corp. (BLAC)

Stock analysis · NASDAQ · Financial Services · Shell Companies

$3.01

Market Cap

$6.98M

PE (TTM)

0.84

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.53

Day Range

$3.01 – $4.43

52-wk Range

$3.01 – $13.40

Avg Volume

N/A

Volume

430.77K

Bellevue Life Sciences Acquisition Corp. (BLAC) is a publicly traded company in the Financial Services sector. Latest price: $3.01. Market cap $6.98M. Trailing PE 0.84. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	0.84×
P/S (TTM)	3.86×
P/B	0.11×
PEG	0.01×
P/FCF (TTM)	-2.43×
EV / EBITDA	-0.64×
EV / Sales	3.35×
Earnings Yield	90.04%
Free Cash Flow Yield	-41.19%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$6.06M
Revenue (TTM)	$1.81M
Net Income (TTM)	$6.29M
Free Cash Flow (TTM)	-$2.97M
Net Debt	-$921.42K
Working Capital	-$12.87M
Gross Margin	35.29%
Operating Margin	-933.75%
Net Margin	671.56%
Return on Equity	12.57%
Return on Invested Capital	-10.61%